[PDF][PDF] Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
Journal of clinical oncology, 2010•researchgate.net
Purpose In approximately 20% of patients with superficial bladder tumors, the tumors
progress to invasive tumors after treatment. Current methods of predicting the clinical
behavior of these tumors prospectively are unreliable. We aim to identify a molecular
signature that can reliably identify patients with high-risk superficial tumors that are likely to
progress to invasive tumors.
progress to invasive tumors after treatment. Current methods of predicting the clinical
behavior of these tumors prospectively are unreliable. We aim to identify a molecular
signature that can reliably identify patients with high-risk superficial tumors that are likely to
progress to invasive tumors.
Purpose
In approximately 20% of patients with superficial bladder tumors, the tumors progress to invasive tumors after treatment. Current methods of predicting the clinical behavior of these tumors prospectively are unreliable. We aim to identify a molecular signature that can reliably identify patients with high-risk superficial tumors that are likely to progress to invasive tumors.
researchgate.net